Gallotta, Valerio
 Distribuzione geografica
Continente #
NA - Nord America 5.748
EU - Europa 4.111
AS - Asia 4.104
SA - Sud America 891
Continente sconosciuto - Info sul continente non disponibili 719
AF - Africa 104
OC - Oceania 12
Totale 15.689
Nazione #
US - Stati Uniti d'America 5.601
SG - Singapore 1.886
DE - Germania 1.110
CN - Cina 924
BR - Brasile 718
SE - Svezia 693
IT - Italia 550
FR - Francia 397
VN - Vietnam 393
PL - Polonia 337
IN - India 214
GB - Regno Unito 203
UA - Ucraina 192
IE - Irlanda 183
FI - Finlandia 122
ID - Indonesia 117
JP - Giappone 114
HK - Hong Kong 104
RU - Federazione Russa 97
BD - Bangladesh 70
CA - Canada 61
AR - Argentina 56
IQ - Iraq 50
TR - Turchia 50
MX - Messico 44
NL - Olanda 37
BE - Belgio 35
ES - Italia 34
EC - Ecuador 32
ZA - Sudafrica 29
PK - Pakistan 22
CL - Cile 19
AT - Austria 18
IR - Iran 17
RO - Romania 17
VE - Venezuela 17
KE - Kenya 16
KR - Corea 16
CO - Colombia 15
UZ - Uzbekistan 15
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
JO - Giordania 13
MA - Marocco 13
CH - Svizzera 12
CI - Costa d'Avorio 11
EG - Egitto 10
PE - Perù 10
PY - Paraguay 10
GR - Grecia 9
IL - Israele 9
KZ - Kazakistan 9
MY - Malesia 9
AU - Australia 8
JM - Giamaica 8
LT - Lituania 7
PH - Filippine 7
BO - Bolivia 6
PA - Panama 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BH - Bahrain 5
DK - Danimarca 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
HN - Honduras 4
LB - Libano 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
HR - Croazia 3
LK - Sri Lanka 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GF - Guiana Francese 2
NO - Norvegia 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
Totale 14.952
Città #
Singapore 1.059
Chandler 847
San Jose 577
Ashburn 543
Warsaw 311
Beijing 209
Dublin 176
New York 155
Ho Chi Minh City 137
San Mateo 131
Los Angeles 126
Ann Arbor 117
Jacksonville 116
Lauterbourg 111
Jakarta 104
Hanoi 100
Tokyo 100
Boston 90
Wilmington 88
Frankfurt am Main 86
Nanjing 85
Rome 84
Hong Kong 83
Houston 74
Nürnberg 71
Dearborn 69
São Paulo 66
Marseille 65
Hefei 61
Hyderabad 61
Milan 61
Princeton 61
Helsinki 58
Cattolica 54
Dallas 54
Moscow 53
The Dalles 47
Redwood City 45
Woodbridge 45
Munich 44
Chicago 41
Fairfield 41
Santa Clara 41
Fuzhou 36
Buffalo 35
Brussels 34
Seattle 33
Lawrence 32
Orem 32
Atlanta 28
Nanchang 28
Boardman 26
Kunming 25
St Louis 25
Shanghai 23
Hangzhou 22
London 22
Rio de Janeiro 22
Augusta 21
Mountain View 21
Turku 21
Phoenix 20
Belo Horizonte 19
Brooklyn 19
Changsha 19
Da Nang 19
Denver 19
Johannesburg 19
Norwalk 19
Leawood 18
Shenyang 18
Tianjin 18
Düsseldorf 17
Lancaster 17
Mumbai 17
Amsterdam 16
Baghdad 16
Bremen 16
Council Bluffs 16
Hebei 16
Memphis 16
Nuremberg 16
San Francisco 16
Seoul 16
Chennai 15
Dhaka 15
Quito 15
Roubaix 15
Toronto 15
Mexico City 14
Paris 14
Poplar 14
Haiphong 13
Izmir 13
Jiaxing 13
Kent 13
Nairobi 13
Stockholm 13
Tashkent 13
Washington 13
Totale 7.656
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 382
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 296
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 291
Optimizing patient selection for secondary cytoreductive surgery in recurrent endometrial cancer 253
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 232
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 222
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer 221
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 213
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 202
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 195
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 191
Urologic surgery in gynecologic oncology: a large single-institution experience 188
Can the Modified Frailty Index (mFI) Predict Intraoperative and Postoperative Complications in Older Women with Endometrial Cancer Undergoing Laparoscopic or Robotic Surgery? A Multicenter Observational Study 187
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 186
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 184
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 181
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 180
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 179
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 175
Airway Closure during Surgical Pneumoperitoneum in Obese Patients 171
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 156
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 156
Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series 154
From palliation to cure: PIPAC for peritoneal malignancies 154
Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients. 151
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 149
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 145
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 144
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 142
Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience 140
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 140
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 140
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 138
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) 138
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study 138
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 137
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 137
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 136
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 136
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 135
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 135
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 131
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 131
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 130
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 130
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 129
Minimally invasive versus open pelvic exenteration in gynecological malignancies: A propensity-matched survival analysis 128
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 127
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 127
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 126
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 126
Could lymphadenectomy be avoided in locally advanced cervical cancer patients administered preoperative chemoradiation? A large-scale retrospective study 124
The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience 124
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 123
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 122
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 122
Lung-protective ventilation during Trendelenburg pneumoperitoneum surgery: A randomized clinical trial 121
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer 121
Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilot Study 121
Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience 121
A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage Endometrial Cancer: The ROMANHY Trial 120
Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study 119
Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach 119
Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach 118
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 116
Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? 116
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 115
Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis 115
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 113
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival 113
STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs 112
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 111
Technological innovation and personalized surgical treatment for early-stage endometrial cancer patients: A prospective multicenter Italian experience to evaluate the novel percutaneous approach 111
Prognostic factors for survival in patients with lung metastases from gynaecological tract cancers 110
Krukenberg tumors: Seed, route and soil 108
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience 108
Laparoscopy vs. Laparotomy for advanced ovarian cancer: A systematic review of the literature 108
Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion 107
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 106
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 106
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs 103
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 103
Clinical Impact of a Surgical Energy Device in Advanced Ovarian Cancer Surgery Including Bowel Resection 103
Robotic Secondary Cytoreduction with 3D Reconstruction for Isolated Recurrent Ovarian Cancer: A Stepwise Approach to Splenectomy 102
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 102
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience 101
Secondary cytoreduction in ovarian cancer: who really benefits? 100
Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up 100
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 99
Minimally invasive secondary cytoreductive surgery for hepato-renal recess isolated recurrence of serous endometrial cancer in BRCA1 mutated patient 97
Enhanced recovery after surgery (ERAS) in gynecology oncology 96
ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery-What We Know and Future Perspectives 93
Total laparoendoscopic single-site surgery (LESS) hysterectomy in low-risk early endometrial cancer: a pilot study 93
Robotic Single-Port Platform in General, Urologic, and Gynecologic Surgeries: A Systematic Review of the Literature and Meta-analysis 93
Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery 93
Surgery after upfront chemoradiation in locally advanced squamous cell vulvar cancer: Analysis of postoperative outcomes and survival 92
Role of robotic surgery in ovarian malignancy 91
Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature 90
Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study 89
Totale 14.671
Categoria #
all - tutte 62.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022969 0 43 15 135 38 20 23 137 40 81 201 236
2022/20232.107 337 301 175 322 120 265 97 134 246 20 51 39
2023/2024882 28 279 16 88 24 115 56 40 12 27 99 98
2024/20251.928 44 45 132 66 144 86 80 75 282 228 403 343
2025/20265.494 801 191 312 656 959 362 863 295 356 416 175 108
2026/2027800 237 563 0 0 0 0 0 0 0 0 0 0
Totale 15.689